|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19934163 |
|
NCBI chrNW_004936546:3,737,908...3,783,492
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17513972 |
|
NCBI chrNW_004936530:71,965...143,940
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27028940 |
|
NCBI chrNW_004936512:5,861,933...5,894,898
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29477364 |
|
NCBI chrNW_004936602:3,037,862...3,044,863
|
|
G |
LOC101954950 |
aromatase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11985600 |
|
NCBI chrNW_004936471:13,107,603...13,136,910
|
|
G |
Pth |
parathyroid hormone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9881647 |
|
NCBI chrNW_004936528:5,081,569...5,084,030
|
|
G |
Pthlh |
parathyroid hormone like hormone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16769263 |
|
NCBI chrNW_004936760:197,525...209,212
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11b |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:15845617 PMID:18496637 PMID:23333834 |
|
NCBI chrNW_004936470:27,571,263...27,598,725
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26319416 |
|
NCBI chrNW_004936747:1,255,803...1,288,252
|
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
associated with Juvenile Polyposis Syndrome;DNA:nonsense mutation:exon:p.Y412X (1236C>G) (human) |
RGD |
PMID:15990641 |
RGD:12880041 |
NCBI chrNW_004936497:12,242,869...12,278,012
|
|
G |
Zmpste24 |
zinc metallopeptidase STE24 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12913070 PMID:17152860 |
|
NCBI chrNW_004936474:22,035,059...22,077,846
|
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20630305 |
|
NCBI chrNW_004936474:7,209,196...7,229,899
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:26270535 |
RGD:11049527 |
NCBI chrNW_004936557:5,834,874...5,838,502
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
|
ISO |
|
RGD |
PMID:14630900 |
RGD:10413909 |
NCBI chrNW_004936526:3,102,468...3,147,601
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:26270535 |
RGD:11049527 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19249596 |
|
NCBI chrNW_004936747:1,255,803...1,288,252
|
|
|
G |
Tnfrsf11a |
TNF receptor superfamily member 11a |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936497:2,944,841...2,986,113
|
|
|
G |
LOC101965998 |
notch receptor 2 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936872:454,273...539,544
|
|
|
G |
F12 |
coagulation factor XII |
|
ISO |
ClinVar Annotator: match by term: Hypophosphatemic Nephrolithiasis/Osteoporosis |
ClinVar |
PMID:8528215 PMID:9354665 PMID:21920016 PMID:23348723 PMID:24029428 PMID:24033266 PMID:25524745 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936597:1,687,511...1,694,782
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
ISO |
ClinVar Annotator: match by term: Hypophosphatemic Nephrolithiasis/Osteoporosis |
ClinVar |
PMID:8528215 PMID:9354665 PMID:21920016 PMID:23348723 PMID:24029428 PMID:24033266 PMID:25524745 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936597:1,667,700...1,684,533
|
|
|
G |
F12 |
coagulation factor XII |
|
ISO |
ClinVar Annotator: match by term: Nephrolithiasis/osteoporosis, hypophosphatemic, 1 |
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004936597:1,687,511...1,694,782
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936597:1,667,700...1,684,533
|
|
|
G |
Slc9a3r1 |
SLC9A3 regulator 1 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936594:119,808...136,620
|
|
|
G |
Lrp5 |
LDL receptor related protein 5 |
|
ISO |
DNA:mutations:exon:c.3446 T > A (p.L1149Q),c.3553 G > A (p.G1185R)(human) |
RGD |
PMID:22487062 |
RGD:12793058 |
NCBI chrNW_004936599:1,746,309...1,814,471
|
|
|
G |
Ctsc |
cathepsin C |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936736:1,201,343...1,240,311
|
|
|
G |
Lmna |
lamin A/C |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936580:5,374,208...5,395,442
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18554282 |
|
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Zmpste24 |
zinc metallopeptidase STE24 |
|
ISO |
ClinVar Annotator: match by term: Mandibuloacral dysostosis |
ClinVar |
|
|
NCBI chrNW_004936474:22,035,059...22,077,846
|
|
|
G |
Mafb |
MAF bZIP transcription factor B |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936561:1,007,273...1,010,548
|
|
|
G |
Banf1 |
BAF nuclear assembly factor 1 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936599:3,553,190...3,555,167
|
|
G |
Eif1ad |
eukaryotic translation initiation factor 1A domain containing |
|
ISO |
ClinVar Annotator: match by term: Nestor-Guillermo progeria syndrome |
ClinVar |
|
|
NCBI chrNW_004936599:3,555,273...3,558,443
|
|
|
G |
Antxr2 |
ANTXR cell adhesion molecule 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12973667 |
|
NCBI chrNW_004936749:1,936,307...2,014,452
|
|
G |
LOC101954979 |
integrin binding sialoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22407340 |
|
NCBI chrNW_004936905:316,459...323,446
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
OMIM:277950, Winchester syndrome |
RGD |
PMID:16542393 |
RGD:1601416 |
NCBI chrNW_004936475:7,801,356...7,825,831
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
|
ISO |
associated with Prostatic Neoplasms |
RGD |
PMID:15894268 |
RGD:9685352 |
NCBI chrNW_004936551:5,388,456...5,395,071
|
|
G |
Pthlh |
parathyroid hormone like hormone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11054717 |
|
NCBI chrNW_004936760:197,525...209,212
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22407340 |
|
NCBI chrNW_004936905:148,956...156,023
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15878362 |
|
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11b |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12548581 |
|
NCBI chrNW_004936470:27,571,263...27,598,725
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18606716 |
|
NCBI chrNW_004936747:1,255,803...1,288,252
|
|
|
G |
Lpcat2 |
lysophosphatidylcholine acyltransferase 2 |
|
ISO |
ClinVar Annotator: match by term: Multicentric osteolysis, nodulosis and arthropathy |
ClinVar |
|
|
NCBI chrNW_004936475:7,830,544...7,889,437
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936475:7,801,356...7,825,831
|
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
|
ISO |
|
RGD |
PMID:10700189 |
RGD:10047094 |
NCBI chrNW_004936487:17,690,206...17,819,619
|
|
G |
Actg1 |
actin gamma 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936594:5,170,711...5,173,251
|
|
G |
Adcy5 |
adenylate cyclase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18029912 |
|
NCBI chrNW_004936725:1,751,272...1,897,937
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
mRNA:increased expression:proximal end of left femur (rat) |
RGD |
PMID:21542009 PMID:22036861 |
RGD:6767561 RGD:7245948 |
NCBI chrNW_004936727:1,418,342...1,422,005
|
|
G |
Antxr2 |
ANTXR cell adhesion molecule 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12973667 |
|
NCBI chrNW_004936749:1,936,307...2,014,452
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936471:21,274,112...21,329,286
|
|
G |
Ar |
androgen receptor |
treatment |
ISO |
|
RGD |
PMID:14600402 PMID:18847323 |
RGD:10043196 RGD:10043198 |
NCBI chrNW_004936635:485,903...647,820
|
|
G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936586:1,782,581...1,809,458
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
|
RGD |
PMID:16644862 |
RGD:10047420 |
NCBI chrNW_004936551:359,134...534,672
|
|
G |
Atp4b |
ATPase H+/K+ transporting subunit beta |
treatment |
ISO |
|
RGD |
PMID:26869358 |
RGD:14696735 |
NCBI chrNW_004936472:168,745...173,996
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:22648569 |
RGD:10054093 |
NCBI chrNW_004936664:2,968,103...2,973,652
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:22648569 |
RGD:10054093 |
NCBI chrNW_004936497:2,209,136...2,373,580
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
|
ISO |
|
RGD |
PMID:17002564 |
RGD:1625350 |
NCBI chrNW_004936485:12,428,765...12,439,570
|
|
G |
Ca2 |
carbonic anhydrase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936544:362,591...379,151
|
|
G |
Calca |
calcitonin related polypeptide alpha |
|
ISO |
|
RGD |
PMID:2502220 |
RGD:734677 |
NCBI chrNW_004936528:3,800,801...3,806,000
|
|
G |
Calcr |
calcitonin receptor |
susceptibility |
ISO |
DNA:SNP:cds:g.1340T>C (human) |
OMIM RGD |
PMID:23137636 |
RGD:10045665 |
NCBI chrNW_004936803:423,558...466,762
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936474:21,854,454...21,881,622
|
|
G |
Cct2 |
chaperonin containing TCP1 subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936545:7,416,257...7,436,024
|
|
G |
Clec11a |
C-type lectin domain containing 11A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27976999 |
|
NCBI chrNW_004936889:476,439...478,620
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
susceptibility |
ISO |
DNA:SNP, haplotype:intron:g.2046G>T (human) |
OMIM RGD |
PMID:23137636 |
RGD:10045665 |
NCBI chrNW_004936490:11,448,552...11,465,836
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936585:5,650,322...5,686,393
|
|
G |
Ctsk |
cathepsin K |
|
ISO |
|
RGD |
PMID:10469835 |
RGD:734856 |
NCBI chrNW_004936580:1,022,762...1,038,020
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
ISO |
|
RGD |
PMID:29882473 |
RGD:14700776 |
NCBI chrNW_004936469:39,794,613...39,798,448
|
|
G |
Daam2 |
dishevelled associated activator of morphogenesis 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30598549 |
|
NCBI chrNW_004936476:19,771,204...19,878,462
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936623:3,115,357...3,130,289
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
ISO |
|
RGD |
PMID:23281008 |
RGD:10045609 |
NCBI chrNW_004936706:1,854,938...1,867,521
|
|
G |
Esr1 |
estrogen receptor 1 |
no_association treatment |
ISO |
DNA:SNP, haplotype:intron:g.938C>T (human) DNA:repeat:5' utr:g.-1174(TA)10-27 (human) DNA:SNPs:intron: (rs2234693, rs9340799) (human) DNA:SNP:intron:397T>C (human) DNA:repeat:intron:IVS5+225(CA)18-25 (human) DNA:SNP:exon:2014G>A (human) |
RGD |
PMID:10773580 PMID:16530497 PMID:16955786 PMID:17896124 PMID:17953702 PMID:20116372 PMID:21421090 PMID:23137636 |
RGD:10045665 RGD:10045825 RGD:10045826 RGD:10045828 RGD:10045834 RGD:10045839 RGD:10045841 RGD:8694129 |
NCBI chrNW_004936489:4,616,839...4,887,179
|
|
G |
Esr2 |
estrogen receptor 2 |
treatment susceptibility |
ISO |
DNA:SNP, haplotype:3'utr:*39A>G (human) DNA:SNP, haplotypes: :-1213T>C (human) DNA:repeat:3' utr: g.dupCA (human) |
RGD |
PMID:16530497 PMID:16777502 PMID:16955786 PMID:21421090 PMID:22948905 |
RGD:10045825 RGD:10045841 RGD:1626507 RGD:7364765 RGD:8694129 |
NCBI chrNW_004936495:7,956,168...8,018,356
|
|
G |
Esrra |
estrogen related receptor alpha |
|
ISO |
|
RGD |
PMID:19936213 |
RGD:10401868 |
NCBI chrNW_004936599:4,898,534...4,922,758
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936576:1,322,406...1,329,743
|
|
G |
Fgb |
fibrinogen beta chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936576:1,306,076...1,313,485
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
ISO |
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18 |
ClinVar |
PMID:5448 PMID:1303173 PMID:1631957 PMID:1978554 PMID:2321910 PMID:2503817 PMID:2572288 PMID:2836867 PMID:3393536 PMID:3446582 PMID:4359638 PMID:4388132 PMID:6015571 PMID:7949118 PMID:8611726 PMID:8860013 PMID:9858856 PMID:10734064 PMID:12367584 PMID:12737938 PMID:14278484 PMID:16356170 PMID:25741868 PMID:26633385 PMID:27287612 PMID:28492532 |
|
NCBI chrNW_004936809:1,269,900...1,285,853
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936709:1,243,149...1,247,782
|
|
G |
Ghr |
growth hormone receptor |
treatment |
ISO |
associated with Uremia;protein:altered expression:osteoblast, osteoclast, chondroblast associated with Cholestasis |
RGD |
PMID:17647196 PMID:19424739 |
RGD:10003128 RGD:10003131 |
NCBI chrNW_004936518:235,996...380,225
|
|
G |
Gorab |
golgin, RAB6 interacting |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18997784 |
|
NCBI chrNW_004936481:16,332,442...16,350,822
|
|
G |
Gpc6 |
glypican 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28869591 |
|
NCBI chrNW_004936472:15,136,656...16,177,597
|
|
G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936469:21,705,421...21,833,143
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936529:997,943...999,123
|
|
G |
Gsn |
gelsolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936487:9,749,755...9,802,787
|
|
G |
Gsr |
glutathione-disulfide reductase |
|
ISO |
protein:decreased expression:blood |
RGD |
PMID:19464221 |
RGD:10401828 |
NCBI chrNW_004936792:531,076...579,083
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
associated with Cystic Fibrosis;DNA:missense mutation:cds:c.313A>G (p.I105V) (human) |
RGD |
PMID:24593045 |
RGD:10401929 |
NCBI chrNW_004936599:2,197,681...2,200,642
|
|
G |
Hfe |
homeostatic iron regulator |
|
ISO |
associated with hemochromatosis |
RGD |
PMID:26829642 |
RGD:14746963 |
NCBI chrNW_004936671:1,940,079...1,947,574
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
|
ISO |
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18 |
ClinVar |
PMID:24088041 PMID:26633545 |
|
NCBI chrNW_004936499:1,002,083...1,109,446
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936483:15,845,777...15,864,341
|
|
G |
Igf1 |
insulin like growth factor 1 |
treatment |
ISO |
associated with Cholestasis associated with Diabetes Mellitus, Experimental associated with Uremia;protein:altered expression:osteoblast, osteoclast, chondroblast |
RGD |
PMID:1466160 PMID:10499542 PMID:17647196 PMID:19424739 |
RGD:10003127 RGD:10003128 RGD:10003131 RGD:10003132 |
NCBI chrNW_004936492:11,709,623...11,784,028
|
|
G |
Igf1r |
insulin like growth factor 1 receptor |
|
ISO |
|
RGD |
PMID:18079194 |
RGD:10045888 |
NCBI chrNW_004936483:4,563,995...4,860,231
|
|
G |
Igf2 |
insulin like growth factor 2 |
treatment |
ISO |
|
RGD |
PMID:12162999 |
RGD:10402555 |
NCBI chrNW_004936816:972,902...981,232
|
|
G |
Igfbp3 |
insulin like growth factor binding protein 3 |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:9284698 |
RGD:10402579 |
NCBI chrNW_004936478:20,511,490...20,518,251
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18 |
ClinVar |
PMID:24088041 PMID:26633545 |
|
NCBI chrNW_004936499:860,179...883,884
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
associated with Arthritis, Rheumatoid |
RGD |
PMID:10555884 |
RGD:6907107 |
NCBI chrNW_004936783:1,210,715...1,218,315
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
|
RGD |
PMID:22997530 |
RGD:7204491 |
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:8182127 |
RGD:8551834 |
NCBI chrNW_004936783:1,447,158...1,466,331
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15995586 |
|
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Il6r |
interleukin 6 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15995586 |
|
NCBI chrNW_004936580:4,055,438...4,081,876
|
|
G |
Irs1 |
insulin receptor substrate 1 |
|
ISO |
mRNA, protein:decreased expression:multiple |
RGD |
PMID:22820932 |
RGD:7207063 |
NCBI chrNW_004936525:9,064,442...9,125,972
|
|
G |
Irs2 |
insulin receptor substrate 2 |
|
ISO |
associated with Diabetes Mellitus, Type 2; protein:decreased expression:liver,kidney, muscle: |
RGD |
PMID:22820932 |
RGD:7207063 |
NCBI chrNW_004936472:2,772,187...2,796,398
|
|
G |
Kl |
klotho |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:9363890 |
RGD:10403047 |
NCBI chrNW_004936472:27,604,681...27,649,613
|
|
G |
Lepr |
leptin receptor |
susceptibility |
ISO |
DNA:polymorphisms:cds:p.K109R,Q223R(human) |
RGD |
PMID:23460508 |
RGD:10411886 |
NCBI chrNW_004936591:5,771,371...5,846,177
|
|
G |
Lgr4 |
leucine rich repeat containing G protein-coupled receptor 4 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 17 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:23644456 |
|
NCBI chrNW_004936540:5,752,319...5,846,074
|
|
G |
LOC101954950 |
aromatase |
|
ISO |
DNA:snps:multiple (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17002564 PMID:20723554 |
RGD:1625350 |
NCBI chrNW_004936471:13,107,603...13,136,910
|
|
G |
LOC101955952 |
dentin sialophosphoprotein |
|
ISO |
protein:decreased expression:incisor dental pulp (rat) |
RGD |
PMID:23974864 |
RGD:12911019 |
NCBI chrNW_004936905:458,062...463,359
|
|
G |
LOC101957714 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22337913 |
|
NCBI chrNW_004936514:1,467,460...1,480,185
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
associated with Hypertension |
RGD |
PMID:19590507 |
RGD:2325225 |
NCBI chrNW_004936541:4,157,847...4,178,156
|
|
G |
LOC101968976 |
leptin |
treatment |
ISO |
associated with chronic obstructive pulmonary disease; protein:decreased expression:serum protein:increased expression:serum (rat) human protein in a rat model |
RGD |
PMID:11459801 PMID:12609558 PMID:21376149 PMID:24250662 |
RGD:10053572 RGD:10053615 RGD:10053630 RGD:5128771 |
NCBI chrNW_004936479:15,394,966...15,411,334
|
|
G |
LOC101969021 |
somatotropin |
|
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:1466160 |
RGD:10003132 |
NCBI chrNW_004936541:4,524,397...4,528,234
|
|
G |
LOC101970144 |
purine nucleoside phosphorylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936877:686,539...692,832
|
|
G |
LOC101970767 |
steroid 17-alpha-hydroxylase/17,20 lyase |
|
ISO |
DNA:snps:multiple (human) |
RGD |
PMID:17002564 |
RGD:1625350 |
NCBI chrNW_004936600:3,097,620...3,102,713
|
|
G |
LOC101973343 |
tubulin alpha-1C chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936512:7,026,107...7,033,804
|
|
G |
LOC101973467 |
D-box binding PAR bZIP transcription factor |
|
ISO |
|
RGD |
PMID:17002564 |
RGD:1625350 |
NCBI chrNW_004936664:2,676,754...2,682,425
|
|
G |
LOC101978603 |
bone gamma-carboxyglutamate protein |
susceptibility |
ISO |
DNA:SNP, haplotype:promoter:g.-298C>T (human) associated with Diabetes Mellitus, type 2;associated with Diabetes Mellitus, type 2; protein:uncercarboxylated:serum |
RGD |
PMID:15108065 PMID:21550389 PMID:23137636 |
RGD:10045665 RGD:6483552 RGD:6483579 |
NCBI chrNW_004936580:5,480,023...5,482,288
|
|
G |
Lrch2 |
leucine rich repeats and calponin homology domain containing 2 |
|
ISO |
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18 |
ClinVar |
PMID:24088041 PMID:26633545 |
|
NCBI chrNW_004936499:673,276...775,860
|
|
G |
Lrp5 |
LDL receptor related protein 5 |
treatment |
ISO |
|
OMIM RGD |
PMID:21977807 PMID:22704852 |
RGD:12793063 RGD:7240519 |
NCBI chrNW_004936599:1,746,309...1,814,471
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16648989 PMID:16936800 |
|
NCBI chrNW_004936596:344,287...373,788
|
|
G |
Luzp4 |
leucine zipper protein 4 |
|
ISO |
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 18 |
ClinVar |
PMID:24088041 PMID:26633545 |
|
NCBI chrNW_004936499:588,532...603,280
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
treatment |
ISO |
|
RGD |
PMID:18442314 |
RGD:10045965 |
NCBI chrNW_004936476:23,237,762...23,310,211
|
|
G |
Mgll |
monoglyceride lipase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936798:681,549...721,645
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
associated with osteoporosis; protein:increased expression:serum |
RGD |
PMID:19411568 |
RGD:5129553 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
|
RGD |
PMID:22704852 |
RGD:7240519 |
NCBI chrNW_004936470:20,480,844...20,485,955
|
|
G |
Nog |
noggin |
|
ISO |
|
RGD |
PMID:12975477 |
RGD:10414323 |
NCBI chrNW_004936490:6,262,651...6,264,069
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
|
ISO |
DNA:silent mutation, haplotype:p.G75G (human) |
RGD |
PMID:16530497 |
RGD:10045825 |
NCBI chrNW_004936505:7,886,327...7,966,969
|
|
G |
Opa1 |
OPA1 mitochondrial dynamin like GTPase |
|
ISO |
ClinVar Annotator: match by term: Osteoporosis |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936711:1,027,531...1,113,796
|
|
G |
Oxct1 |
3-oxoacid CoA-transferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936518:924,840...1,057,201
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936594:5,368,199...5,379,215
|
|
G |
Park7 |
Parkinsonism associated deglycase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936623:2,422,780...2,436,817
|
|
G |
Pcna |
proliferating cell nuclear antigen |
|
ISO |
protein:increased expression:osteoblast: |
RGD |
PMID:22550338 |
RGD:10045656 |
NCBI chrNW_004936485:13,766,221...13,771,215
|
|
G |
Pdlim4 |
PDZ and LIM domain 4 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936647:2,891,025...2,905,197
|
|
G |
Pgls |
6-phosphogluconolactonase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936596:3,414,003...3,422,467
|
|
G |
Pkm |
pyruvate kinase M1/2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936471:31,589,322...31,617,891
|
|
G |
Plek |
pleckstrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936491:12,762,421...12,818,249
|
|
G |
Pls3 |
plastin 3 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936499:246,042...335,440
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:3017235 PMID:4367732 PMID:6143199 PMID:6254450 PMID:19153526 |
|
NCBI chrNW_004936493:7,060,747...7,065,276
|
|
G |
Prdx3 |
peroxiredoxin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936486:8,597,479...8,606,727
|
|
G |
Psma2 |
proteasome 20S subunit alpha 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936478:18,083,525...18,095,088
|
|
G |
Psma5 |
proteasome 20S subunit alpha 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936704:905,277...928,364
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
treatment |
ISO |
|
RGD |
PMID:16442794 |
RGD:10043381 |
NCBI chrNW_004936518:1,903,636...1,916,746
|
|
G |
Pth |
parathyroid hormone |
treatment |
ISO |
CTD Direct Evidence: therapeutic protein:decreased expression:serum (rat) |
RGD CTD |
PMID:15710971 PMID:17317460 PMID:17882678 PMID:19578808 PMID:21306167 PMID:22312238 PMID:23161222 PMID:30639440 |
RGD:7242793 RGD:7242907 |
NCBI chrNW_004936528:5,081,569...5,084,030
|
|
G |
Rab7b |
RAB7B, member RAS oncogene family |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936557:6,504,562...6,519,219
|
|
G |
Ren |
renin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18847324 |
|
NCBI chrNW_004936567:598,044...607,628
|
|
G |
Rsu1 |
Ras suppressor protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936520:10,419,405...10,602,820
|
|
G |
Ryr1 |
ryanodine receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Osteoporosis |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936801:1,185,615...1,298,416
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
ISO |
|
RGD |
PMID:22555620 PMID:25377437 |
RGD:10047129 RGD:10053568 |
NCBI chrNW_004936521:10,296,097...10,316,673
|
|
G |
Sod2 |
superoxide dismutase 2 |
no_association susceptibility |
ISO |
DNA:SNPs:5' utr, exon, intron:multiple DNA:SNPs:intron, exon:g.31A>G, g.327C>T (p.A16V) (rs5746094, rs4880) (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18924182 PMID:26336112 |
RGD:11035299 |
NCBI chrNW_004936489:11,178,338...11,191,601
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
treatment |
ISO |
associated with Uremia;protein:increased expression:osteoblast, osteoclast CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12706579 PMID:17647196 |
RGD:10003128 |
NCBI chrNW_004936661:3,742,080...3,758,266
|
|
G |
Tln1 |
talin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936524:3,693,679...3,727,055
|
|
G |
Tnfrsf11a |
TNF receptor superfamily member 11a |
|
ISO |
|
RGD |
PMID:17002564 |
RGD:1625350 |
NCBI chrNW_004936497:2,944,841...2,986,113
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17667143 |
|
NCBI chrNW_004936470:27,571,263...27,598,725
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
|
RGD |
PMID:17002564 |
RGD:1625350 |
NCBI chrNW_004936474:908,414...935,765
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
|
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:17002564 PMID:17882678 |
RGD:1625350 |
NCBI chrNW_004936747:1,255,803...1,288,252
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936709:948,151...951,430
|
|
G |
Tpm4 |
tropomyosin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936596:4,406,301...4,423,775
|
|
G |
U2af1 |
U2 small nuclear RNA auxiliary factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936500:937,537...967,791
|
|
G |
Vcl |
vinculin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936521:5,051,077...5,163,036
|
|
G |
Vdr |
vitamin D receptor |
no_association |
ISO |
associated with Cystic Fibrosis |
RGD |
PMID:16713399 |
RGD:4889871 |
NCBI chrNW_004936512:5,741,836...5,800,999
|
|
G |
Wdr1 |
WD repeat domain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18924182 |
|
NCBI chrNW_004936477:16,643,142...16,682,450
|
|
G |
Wnt1 |
Wnt family member 1 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Bone mineral density quantitative trait locus 16 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:23499309 PMID:23656646 |
|
NCBI chrNW_004936512:6,781,001...6,785,358
|
|
G |
Zdhhc13 |
zinc finger DHHC-type palmitoyltransferase 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20548961 |
|
NCBI chrNW_004936654:220,391...267,383
|
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936504:4,762,251...4,799,789
|
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
ISO |
protein:increased expression:femur (rat) |
RGD |
PMID:19736603 |
RGD:2315910 |
NCBI chrNW_004936659:1,598,252...1,642,615
|
|
G |
Ar |
androgen receptor |
|
ISO |
|
RGD |
PMID:12593895 |
RGD:1578682 |
NCBI chrNW_004936635:485,903...647,820
|
|
G |
Bmp15 |
bone morphogenetic protein 15 |
susceptibility |
ISO |
DNA:SNPs, haplotype:5' utr, intron:g.-9C>G, IVS1+905A>G (human) |
RGD |
PMID:22335445 |
RGD:10045849 |
NCBI chrNW_004936873:109,156...115,498
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17227729 |
|
NCBI chrNW_004936533:3,601,270...3,637,128
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
ClinVar Annotator: match by term: Postmenopausal osteoporosis |
ClinVar |
PMID:2037280 PMID:7695699 PMID:7942841 PMID:8218237 PMID:8408653 PMID:8613526 PMID:8669434 PMID:8808594 PMID:9016532 PMID:9067755 PMID:9295084 PMID:9443882 PMID:10931857 PMID:12590186 PMID:15024692 PMID:15024745 PMID:15741671 PMID:15864348 PMID:15931785 PMID:17078022 PMID:17309652 PMID:18412368 PMID:18553566 PMID:18704262 PMID:19344236 PMID:19358256 PMID:21249479 PMID:21567126 PMID:21667357 PMID:22589248 PMID:22753364 PMID:24390061 PMID:25086671 PMID:25741868 PMID:25944380 PMID:25963598 PMID:26177859 PMID:26467025 PMID:27132807 PMID:27509835 PMID:27510842 PMID:27748872 PMID:28378289 PMID:28492532 |
|
NCBI chrNW_004936490:11,448,552...11,465,836
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
|
ISO |
ClinVar Annotator: match by term: Postmenopausal osteoporosis |
ClinVar |
PMID:1463018 PMID:2052622 PMID:7695699 PMID:7860070 PMID:8094076 PMID:8218237 PMID:8786074 PMID:9016532 PMID:9272740 PMID:9594376 PMID:16705691 PMID:17078022 PMID:19344236 PMID:21520333 PMID:22589248 PMID:25326637 PMID:25450603 PMID:25741868 PMID:25944380 PMID:26604951 PMID:27519266 PMID:28492532 |
|
NCBI chrNW_004936585:5,650,322...5,686,393
|
|
G |
Esr1 |
estrogen receptor 1 |
susceptibility treatment |
ISO |
DNA:SNPs, haplotype:intron: (rs2234693, rs9340799) (human) DNA:SNP:intron:IVS1T>C (human) |
RGD |
PMID:16604479 PMID:16972020 |
RGD:10045838 RGD:8158082 |
NCBI chrNW_004936489:4,616,839...4,887,179
|
|
G |
Esr2 |
estrogen receptor 2 |
susceptibility |
ISO |
DNA:SNP: :-1213T>C (human) DNA:SNP, haplotype:3'utr:*39A>G (human) DNA:repeat:intron:IVS5-3919(CA)18-26 (human) |
RGD |
PMID:16777502 PMID:17945165 PMID:22335445 |
RGD:10045847 RGD:10045849 RGD:1626507 |
NCBI chrNW_004936495:7,956,168...8,018,356
|
|
G |
Fdps |
farnesyl diphosphate synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31774873 |
|
NCBI chrNW_004936580:4,799,354...4,808,406
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
|
ISO |
protein:increased expression: : |
RGD |
PMID:24101107 |
RGD:10044241 |
NCBI chrNW_004936606:4,555,034...4,561,961
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
ISO |
|
RGD |
PMID:18067744 PMID:24023068 |
RGD:10402191 RGD:10402540 |
NCBI chrNW_004936495:5,770,988...5,816,157
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:11063288 |
RGD:10045861 |
NCBI chrNW_004936492:11,709,623...11,784,028
|
|
G |
Igf2 |
insulin like growth factor 2 |
treatment |
ISO |
|
RGD |
PMID:16753016 |
RGD:10402556 |
NCBI chrNW_004936816:972,902...981,232
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9032749 |
|
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9032749 |
|
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Il7 |
interleukin 7 |
treatment |
ISO |
|
RGD |
PMID:23662133 |
RGD:10402930 |
NCBI chrNW_004936702:110,625...162,957
|
|
G |
LOC101954950 |
aromatase |
|
ISO |
DNA:snps:exon:multiple (human) |
RGD |
PMID:17118999 |
RGD:1600860 |
NCBI chrNW_004936471:13,107,603...13,136,910
|
|
G |
Lrp5 |
LDL receptor related protein 5 |
|
ISO |
ClinVar Annotator: match by term: Postmenopausal osteoporosis |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936599:1,746,309...1,814,471
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
susceptibility |
ISO |
DNA:silent mutation:cds:p.G75G (human) |
RGD |
PMID:22335445 |
RGD:10045849 |
NCBI chrNW_004936505:7,886,327...7,966,969
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
treatment |
ISO |
|
RGD |
PMID:11917107 |
RGD:10003045 |
NCBI chrNW_004936518:1,903,636...1,916,746
|
|
G |
Pth |
parathyroid hormone |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20567999 |
|
NCBI chrNW_004936528:5,081,569...5,084,030
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
ISO |
|
RGD |
PMID:17537919 |
RGD:1642610 |
NCBI chrNW_004936675:216,970...325,670
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10750555 |
|
NCBI chrNW_004936661:3,742,080...3,758,266
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9032749 |
|
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Vdr |
vitamin D receptor |
treatment |
ISO |
DNA:SNP:exon: (rs2228570) (human) |
RGD |
PMID:16604479 |
RGD:8158082 |
NCBI chrNW_004936512:5,741,836...5,800,999
|
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chrNW_004936469:16,721,306...16,778,249
|
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936469:16,721,306...16,778,249
|
|
|
G |
Ddx58 |
DExD/H-box helicase 58 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936524:1,141,840...1,200,638
|
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936831:799,948...946,139
|
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936722:1,447,189...1,457,632
|
|